PERCEPTIVE ADVISORS LLC
Q3 2024 13F-HR Holdings
Net value change ($000)
+574,949
(13.8%)
New positions
14
Sold out positions
19
Turnover %
17.5%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2024
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| VRNA | 146,517 | 416.3% |
| NUVL | 111,403 | 57.6% |
| ACLX | 110,068 | 51.3% |
| PCVX | 91,049 | 64.7% |
| VKTX | 69,386 | 181.4% |
| CNTA | 64,936 | 182.8% |
| ARGX | 57,711 | 860.2% |
| RYTM | 45,003 | 31.8% |
| VRDN | 42,758 | 201.4% |
| IOVA | 41,956 | 20.2% |
Top Reduces (Value $000, Stocks/ETFs)
| Cerevel Therapeutics Holdings, Inc. | -441,402 | -100.0% |
| MDGL | -74,130 | -100.0% |
| NBIX | -65,020 | -72.7% |
| VRCA | -41,459 | -80.1% |
| SpringWorks Therapeutics, Inc. | -40,087 | -64.4% |
| BBIO | -30,785 | -100.0% |
| NTRA | -29,465 | -51.3% |
| CRNX | -29,087 | -44.0% |
| MDT | -16,533 | -42.8% |
| CGEM | -13,079 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
65,910
(1.4% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|